Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Need To Know: Analysts Are Much More Bullish On Nektar Therapeutics (NASDAQ:NKTR) Revenues
10:24am, Monday, 06'th Apr 2020
Celebrations may be in order for Nektar Therapeutics (NASDAQ:NKTR) shareholders, with the analysts delivering a...
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Buy" by Analysts
10:00am, Monday, 06'th Apr 2020
Nektar Therapeutics (NASDAQ:NKTR) has been given a consensus recommendation of “Buy” by the twenty brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst h
Cubist Systematic Strategies LLC Has $985,000 Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)
09:08am, Monday, 06'th Apr 2020
Cubist Systematic Strategies LLC raised its position in shares of Nektar Therapeutics (NASDAQ:NKTR) by 47.4% in the 4th quarter, according to the company in its most recent disclosure with the Securit
Incyte details late-stage data on ruxolitinib cream for atopic dermatitis
06:55pm, Sunday, 05'th Apr 2020
Following up on its initial announcements in January and February, Incyte (NASDAQ:INCY) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2, evaluating a topica
Mizuho Securities Maintains a Buy Rating on Xeris Pharmaceuticals (XERS)
12:21pm, Friday, 03'rd Apr 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Xeris Pharmaceuticals (XERS) today and set a price target of $18.00. The company's shares
Mizuho Securities Maintains a Buy Rating on Xeris Pharmaceuticals (XERS)
12:21pm, Friday, 03'rd Apr 2020
Mizuho Securities analyst
Difei Yang
maintained a
Buy
rating on Xeris Pharmaceuticals (
XERS
–
Research Report
) today and set a price target of
$18.00
. The company’s shares closed last Thursday
Nektar Therapeutics (NASDAQ:NKTR) Lifted to "Neutral" at Goldman Sachs Group
10:26am, Friday, 03'rd Apr 2020
Goldman Sachs Group upgraded shares of Nektar Therapeutics (NASDAQ:NKTR) from a sell rating to a neutral rating in a report released on Monday, BenzingaRatingsTable reports. The firm currently has $20
First Republic Investment Management Inc. Sells 2,019 Shares of Nektar Therapeutics (NASDAQ:NKTR)
09:46am, Friday, 03'rd Apr 2020
First Republic Investment Management Inc. lessened its stake in Nektar Therapeutics (NASDAQ:NKTR) by 15.0% during the fourth quarter, according to its most recent filing with the Securities and Exchan
Nektar valuation unlikely to be hurt much by COVID-19, says Mizuho NKTR
11:43am, Thursday, 02'nd Apr 2020
Nektar valuation unlikely to be hurt much by COVID-19, says Mizuho Mizuho NKTR
RedHill Biopharma Completes Acquisition of Movantik from AstraZeneca
11:00am, Thursday, 02'nd Apr 2020
RedHill to promote Movantik® in the U.S. to expanded call points, including gastroenterologists, primary care physicians and additional specialists, along with Talicia® and.
Nektar Therapeutics (NKTR) Gets a Buy Rating from Mizuho Securities
09:09am, Thursday, 02'nd Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Nektar Therapeutics (NKTR), with a price target of $35.00. The
Nektar Therapeutics (NKTR) Gets a Buy Rating from Mizuho Securities
09:09am, Thursday, 02'nd Apr 2020
In a report released today,
Difei Yang
from Mizuho Securities maintained a
Buy
rating on Nektar Therapeutics (
NKTR
–
Research Report
), with a price target of
$35.00
. The company’s shares closed
Private Asset Management Inc Buys Uber Technologies Inc, Treehouse Foods Inc, New York ...
12:00am, Thursday, 02'nd Apr 2020Canaccord Genuity Keeps Their Buy Rating on Nektar Therapeutics (NKTR)
10:18am, Wednesday, 01'st Apr 2020
In a report released today, Arlinda Lee from Canaccord Genuity reiterated a Buy rating on Nektar Therapeutics (NKTR), with a price target of $25.00. The
